Ownership stake disclosure by BARCLAYS PLC (amended)
BARCLAYS PLC, filed by
RVPH
REVIVA PHARMACEUTICALS HOLDINGS, INC. SEC filings
Every EDGAR filing for REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH), newest first, with AI summaries and stories.
- Ticker
- RVPH
- CIK
- 1742927
- Latest filing
- Aug 13
Next: earnings expected ~Nov 16 · 10-Q expected ~Nov 16 (deadline Nov 16)
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINESCHEDULE 13G/AREVIVA PHARMACEUTICALS HOLDINGS, INC.RVPHLIVE NOTABLE10-QREVIVA PHARMACEUTICALS HOLDINGS, INC.RVPHLIVE ROUTINE8-KREVIVA PHARMACEUTICALS HOLDINGS, INC.RVPHLIVE ROUTINESCHEDULE 13G/AREVIVA PHARMACEUTICALS HOLDINGS, INC.RVPHLIVE Ownership stake disclosure by INTEGRATED CORE STRATEGIES (US) LLC (amended)
INTEGRATED CORE STRATEGIES (US) LLC, filed by
ROUTINESCHEDULE 13G/AREVIVA PHARMACEUTICALS HOLDINGS, INC.RVPHLIVE Ownership stake disclosure by UBS Group AG (amended)
UBS Group AG, filed by
NOTABLE25-NSEREVIVA PHARMACEUTICALS HOLDINGS, INC.RVPHLIVE Nasdaq Stock Market LLC, filed by
ROUTINESCHEDULE 13G/AREVIVA PHARMACEUTICALS HOLDINGS, INC.RVPHLIVE Ownership stake disclosure by CVI Investments, Inc. (amended)
CVI Investments, Inc., filed by
ROUTINESCHEDULE 13GREVIVA PHARMACEUTICALS HOLDINGS, INC.RVPHLIVE Ownership stake disclosure by BARCLAYS PLC
BARCLAYS PLC, filed by
NOTABLE10-QREVIVA PHARMACEUTICALS HOLDINGS, INC.RVPHLIVE ROUTINE8-KREVIVA PHARMACEUTICALS HOLDINGS, INC.RVPHLIVE ROUTINE8-KREVIVA PHARMACEUTICALS HOLDINGS, INC.RVPHLIVE ROUTINESCHEDULE 13GREVIVA PHARMACEUTICALS HOLDINGS, INC.RVPHLIVE Ownership stake disclosure by UBS Group AG
UBS Group AG, filed by
ROUTINE8-KREVIVA PHARMACEUTICALS HOLDINGS, INC.RVPHLIVE ROUTINESCHEDULE 13GREVIVA PHARMACEUTICALS HOLDINGS, INC.RVPHLIVE Ownership stake disclosure by INTEGRATED CORE STRATEGIES (US) LLC
INTEGRATED CORE STRATEGIES (US) LLC, filed by
ROUTINES-8REVIVA PHARMACEUTICALS HOLDINGS, INC.RVPHLIVE ROUTINE8-KREVIVA PHARMACEUTICALS HOLDINGS, INC.RVPHLIVE NOTABLE10-KREVIVA PHARMACEUTICALS HOLDINGS, INC.RVPHLIVE ROUTINESCHEDULE 13GREVIVA PHARMACEUTICALS HOLDINGS, INC.RVPHLIVE Ownership stake disclosure by CVI Investments, Inc.
CVI Investments, Inc., filed by
NOTABLESCHEDULE 13D/AREVIVA PHARMACEUTICALS HOLDINGS, INC.RVPHLIVE Ownership stake disclosure by Parag Saxena (amended)
Parag Saxena, filed by
ROUTINE4REVIVA PHARMACEUTICALS HOLDINGS, INC.RVPHLIVE 2 insider filings
Narayan Prabhu, insider filing for RVPH
Show all 2
- 4Insider filing for RVPH
- 4Insider filing for RVPH
Narayan Prabhu, reporting
ROUTINE8-KREVIVA PHARMACEUTICALS HOLDINGS, INC.RVPHLIVE ROUTINE424B5REVIVA PHARMACEUTICALS HOLDINGS, INC.RVPHLIVE ROUTINE424B5REVIVA PHARMACEUTICALS HOLDINGS, INC.RVPHLIVE ROUTINE8-KREVIVA PHARMACEUTICALS HOLDINGS, INC.RVPHLIVE ROUTINESCHEDULE 13G/AREVIVA PHARMACEUTICALS HOLDINGS, INC.RVPHLIVE Ownership stake disclosure by 683 Capital Management, LLC (amended)
683 Capital Management, LLC, filed by
ROUTINE8-KREVIVA PHARMACEUTICALS HOLDINGS, INC.RVPHLIVE ROUTINESCHEDULE 13G/AREVIVA PHARMACEUTICALS HOLDINGS, INC.RVPHLIVE Ownership stake disclosure by INTEGRATED CORE STRATEGIES (US) LLC (amended)
INTEGRATED CORE STRATEGIES (US) LLC, filed by
ROUTINE8-KREVIVA PHARMACEUTICALS HOLDINGS, INC.RVPHLIVE NOTABLESCHEDULE 13D/AREVIVA PHARMACEUTICALS HOLDINGS, INC.RVPHWLIVE Ownership stake disclosure by Parag Saxena (amended)
Parag Saxena, filed by
ROUTINE4REVIVA PHARMACEUTICALS HOLDINGS, INC.RVPHLIVE 4 insider filings
Leslie D. Funtleyder, insider filing for RVPH
Show all 4
- 4Insider filing for RVPH
- 4Insider filing for RVPH
- 4Insider filing for RVPH
- 4Insider filing for RVPH
Leslie D. Funtleyder, reporting
NOTABLE25-NSEREVIVA PHARMACEUTICALS HOLDINGS, INC.RVPHLIVE Nasdaq Stock Market LLC, filed by
ROUTINEDEFA14AREVIVA PHARMACEUTICALS HOLDINGS, INC.RVPHLIVE ROUTINE8-KREVIVA PHARMACEUTICALS HOLDINGS, INC.RVPHWLIVE REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPHW) filed an 8-K reporting a leadership change, with the company's Chief Executive Officer stepping down.
NOTABLE10-QREVIVA PHARMACEUTICALS HOLDINGS, INC.RVPHWLIVE REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPHW) filed its Q3 2025 10-Q report, providing investors with an update on the company's financial performance and operational status.
ROUTINEARSREVIVA PHARMACEUTICALS HOLDINGS, INC.LIVE ROUTINEDEFA14AREVIVA PHARMACEUTICALS HOLDINGS, INC.LIVE ROUTINEDEF 14AREVIVA PHARMACEUTICALS HOLDINGS, INC.LIVE